Nephroprotective effect of sodium-glucose cotransporter-2 inhibitors in patients with atrial fibrillation and chronic kidney disease
Aim. To evaluate the changes of renal function during treatment with sodium-glucose cotransporter-2 (SGLT-2) inhibitors in patients with atrial fibrillation (AF) and chronic kidney disease (CKD).Material and methods. A total of 100 patients with AF and stage 3-4 CKD were included. Serum creatinine l...
I tiakina i:
| Ngā kaituhi matua: | , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Russo |
| I whakaputaina: |
«SILICEA-POLIGRAF» LLC
2026-06-01
|
| Rangatū: | Кардиоваскулярная терапия и профилактика |
| Ngā marau: | |
| Urunga tuihono: | https://cardiovascular.elpub.ru/jour/article/view/4629 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|